ATIM-39. IMPROVED SURVIVAL NOTED IN GLIOBLASTOMA PATIENTS TREATED WITH ADJUVANT TLR-3 AGONIST IN SETTING OF AUTOLOGOUS LYSATE-PULSED DC VACCINATION

Despite advances in the understanding of glioblastoma multiforme (GBM) molecular biology, genomics, and tumor microenvironment, prognosis for patients diagnosed with this disease remains dismal with standard therapies. We and others have shown utility in dendritic cell (DC) vaccination as an active...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Antonios, Joseph, Everson, Richard, Soto, Horacio, Khattab, Sara, Bethel, Jacob, Sun, Matthew, Mochizuki, Aaron, Lee, Alexander, Odesa, Sylvia, Billingslea-Yoon, Emma, Moughon, Diana, Wang, Anthony, Cloughesy, Tim, Prins, Robert, Liau, Linda
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216157/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.034
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados